About History Products VaxxiKnowledge News Careers Contact Search for… Search News Vaxxinova Buys Newport Laboratories from Boehringer Ingelheim Worthington, MN – Sept. 30, 2021 – Vaxxinova announced today that it has purchased Newport Laboratories, a company that manufactures custom-made vaccines for swine and cattle, from Boehringer Ingelheim. About 100 people work at Newport Laboratories in Worthington, Minnesota. They help veterinarians and livestock producers address animal health issues through diagnostic testing and production of […] Read more → Webinar Autogenous Vaccines on May 27th May 6, 2021 – Cuxhaven, Germany On May 27th, 2021 at 4 PM CET Dr. Heike Bigmore, KAM with Vaxxinova Autogenous Vaccines GmbH, will talk about the use of autogenous vaccines as a tool in disease control and mitigation of antimicrobial resistance (AMR) in animal production. The webinar, hosted by EW Nutrition, is titled Autogenous […] Read more → Vaxxinova US Announces USDA Approval of Vaxxon® SRP® Pasteurella March 15, 2021 – Wilmar, MN, USA Vaxxinova US is announcing USDA approval of their new Vaxxon® SRP® Pasteurella vaccine. Categorized by USDA as a Pasteurella Multocida Bacterial Extract, it is an effective, innovative and safe vaccine against fowl cholera in chickens. Vaxxon SRP Pasteurella provides the industry a new category for long-term protection of […] Read more → Vaxxinova US gains market rights to SRP cattle vaccine from Zoetis Dec 16, 2020 – Wilmar, MN, USA Vaxxinova US has acquired marketing rights from Zoetis for a vaccine against Salmonella in cattle. Until now, the SRP Salmonella vaccine – the first USDA-licensed vaccine to use SRP technology – was manufactured by Vaxxinova US but marketed by Zoetis. With the latest license acquisition, Vaxxinova US now […] Read more → “Boerderij” article on autogenous vaccines Dutch farmers Magazine “Boerderij” published an article on autogenous vaccines in its June 16, 2020 edition. The article mentions how autogenous vaccines can contribute to reduced antibiotic use in swine and Vaxxinova’s contribution to this. Read the full article here. Read more → Vaxxinova announces Director R&D and Director RA Nijmegen, The Netherlands, Wednesday June 3, 2020. Vaxxinova® Nederland BV is pleased to announce two new directors to its team as per June 1, 2020. Both positions are based in Nijmegen. Mrs. Mirjam van der Sluijs will take up the role of Director R&D Nijmegen. As Director R&D Nijmegen Mirjam will lead the R&D and […] Read more → Appointment Managing Director for Vaxxinova Norway and Chile Nijmegen, The Netherlands, Tuesday June 2, 2020. Vaxxinova® International announces that starting June 1, 2020, Dr. Matias del Campo will be the Managing Director for Vaxxinova Norway and Vaxxinova Chile. Matias will be responsible for the global cold-water aquaculture business. Matias is an Aquaculture Engineer from the University Andres Bello in Chile and holds a […] Read more → Vaxxon® SRP® SE licensed in USA Nijmegen, The Netherlands, Wednesday January 22, 2020. Vaxxinova is pleased to announce that last week the USDA granted Epitopix the license for Vaxxon® SRP® SE, a poultry vaccine which has been shown to have an effect against colonization of Salmonella Enteritidis in the reproductive tract. Vaxxon® SRP® SE uses innovative siderophore receptor and porin (SRP) […] Read more → Vaxxinova invites you to IPPE 2020 Nijmegen, The Netherlands, Friday January 17, 2020. In January 2020, Vaxxinova will be present at the IPPE 2020 trade show in Atlanta. Our team is ready to meet you at booth C10361. The show is open to visitors on Tue Jan 28 (10 AM – 5 PM), Wed Jan 29 (9AM – 5PM), Thu Jan […] Read more → Vaxxinova displays scientific posters at WVPAC 2019 in Bangkok Nijmegen, The Netherlands, Monday September 23 2019. At the WVPAC 2019 in Bangkok Vaxxinova displayed three posters on Infectious Bronchitis (IB), Avian Influenza (AI) and Immunosuppression. Many attendants stopped by the poster area to read them and discuss with the authors. For those that were not able to attend the WVPAC in person, follow the […] Read more → Posts navigation Page 1 Page 2 Next page Vaxxinova® International BV Transistorweg 5 6534AT Nijmegen The Netherlands +31 (0)24 2048600 Contact us: info@vaxxinova.com Follow us on Press inquiries: press@vaxxinova.com ©by iT-novative Design by Haltenbanken Privacy Policy